A Rosell, S Havervall, F von Meijenfeldt… - … and Vascular Biology, 2021 - Am Heart Assoc
Objective: Patients with coronavirus disease 2019 (COVID-19) have a high rate of thrombosis. We hypothesized that severe acute respiratory syndrome coronavirus 2 infection …
FC Koehler, V Di Cristanziano, MR Späth… - Clinical Kidney …, 2022 - academic.oup.com
Hantavirus-induced diseases are emerging zoonoses with endemic appearances and frequent outbreaks in different parts of the world. In humans, hantaviral pathology is …
N Mackman, ATA Sachetto… - Current Opinion in …, 2022 - journals.lww.com
We recommend isolating EVs from plasma and measuring TF activity using a functional assay in the presence and absence of an anti-TF antibody. We do not recommend using …
WC Schrottmaier, A Schmuckenschlager… - Thrombosis …, 2024 - Elsevier
Thrombocytopenia is a cardinal symptom of hantavirus-induced diseases including Puumala virus (PUUV)-induced hemorrhagic fever with renal syndrome (HFRS), which is …
Background Puumala orthohantavirus (PUUV) causes hemorrhagic fever with renal syndrome (HFRS). Patients with HFRS have an activated coagulation system with increased …
W Chen, H Du, H Hu, J Lian, H Jiang, J Li… - BMC Infectious …, 2024 - Springer
Abstract Background Hantaan virus (HTNV), Seoul virus (SEOV) and Puumala virus (PUUV) are major serotypes of the Hantavirus, which can cause hemorrhagic fever with renal …
Y Hisada, N Mackman - JoVE (Journal of Visualized Experiments), 2023 - jove.com
Tissue factor (TF) is a transmembrane receptor for factor (F) VII and FVIIa. The TF/FVIIa complex initiates the coagulation cascade by activating both FIX and FX. TF is released from …